Division of
. Inclusion of the immunoglobulin heavy chain intronic enhancer (E) in the rehuman RAG1 promoters that display activity in lymphoid and nonlymphoid cell lines, the murine RAG2 promoter porter construct resulted in 10% to 20% GFP ϩ cells. Control experiments revealed that transfection efficiency displays lymphoid-specific activity and is regulated differently in B and T cell lines (Lauring and Schlissel, was comparable among the various reporter constructs (data not shown). Therefore, the most likely explanation 1999; Wang et al., 2000) . Given the complexity of their expression patterns, we and others have speculated for the lack of GFP expression in the promoter-only constructs is that RAG promoters are unable to overthat regulated RAG expression requires sequences in addition to promoters such as enhancers, locus control come the repressive effects of neighboring chromatin structure when integrated into chromosomal DNA. regions (LCRs), or insulators.
To identify potential regulatory elements in the RAG Interestingly, Erag, which showed very modest RAG2 promoter stimulation in the transient transfection assay, locus, we devised a novel reporter construct in which GFP expression is driven by either RAG1 or RAG2 prohad a much greater effect on chromosomal reporter construct activity (30%-40% GFP ϩ cells) than did the moter in conjunction with potential enhancer sequences from the RAG locus in stably transfected cell lines. Using E control ( Figure 1C , compare upper and middle panels). This effect was apparent in reporter constructs this assay system, we identified a highly conserved RAG locus enhancer. Targeted deletion of this element in based on the RAG1 promoter as well ( Figure 1C, Figure 1C , middle panels and data not shown) In an attempt to identify cis-acting elements that contribfailed to rescue RAG promoter activity in stably transute to high-level, tissue-, and stage-specific expression fected cells, verifying the specificity of the Erag effect of RAG genes, we initially tested restriction fragments on the RAG1 and RAG2 promoters. We also found that generated from an ‫021ف‬ kb P1 bacteriophage clone of Erag shares with other classic enhancers the ability to the murine RAG locus for the ability to enhance RAG-2 function in either orientation ( Figure 1C , middle panels). promoter activity in a transient transfection luciferase
To determine whether Erag-dependent chromosomal assay. These studies led to the identification of a 2.3 kb reporter construct activity was variegated within individXbaI fragment (Fragment C in Figure 1A ; referred to ual transfectant clones, we generated 49 single-cell hereafter as Erag) located ‫22ف‬ kb 5Ј of the RAG2 first clones from the pool of 220-8 cells stably transfected exon that consistently gave ‫-2ف‬fold stimulation of prowith the Erag-RAG2 reporter shown in Figure 1C . Each moter activity upon transfection into the Abelson virus clone demonstrated uniform GFP expression levels transformed pro-B cell line, 220-8 (data not shown).
ranging from none (36%) to ‫-01ف‬fold above background While this enhancement effect was reproducible, its (10%; see Supplemental Figure S1 at http://www.immunity. magnitude led us to doubt the biological relevance of com/cgi/content/full/19/1/105/DC1). Thus, we conclude Erag. To determine whether Erag activity might be more that Erag allows the RAG1 or RAG2 promoter to overstriking within the context of chromatin structure, we come the repressive effects of chromatin structure at designed a stable transfection assay of enhancer activonly a subset of integration sites. ity. As depicted in Figure 1B , the chromosomal reporter construct consists of an enhancer test site 5Ј of either the murine RAG1 or RAG2 promoter that drives expresErag Activates Transcription Specifically in RAG-Expressing B Cell Lines sion of a green fluorescent protein (GFP) cDNA. In addition, the construct contains a neomycin resistance cas-
The results described above demonstrate that Erag is capable of activating RAG1 and RAG2 promoter activity sette for selection of stable transfectants separated from the reporter cassette by two copies of chicken in the 220-8 pro-B cell line. We went on to test the ability of Erag to regulate the RAG promoters in other B cell, ␤-globin insulator (Chung et al., 1993) Figure 5A, top panel) .
In addition, we found that dsDNA breaks at the J 1 Given the apparently exclusive effect of Erag deletion on RAG activity in the B cell lineage, we hypothesized RSS were decreased at least 10-fold in pre-B cells purified from Erag 
E2A Binds to Erag in Pro-B Cell Lines and Activates an Erag-Dependent Reporter Construct in Nonlymphoid Cells
Computational analysis of the Erag sequence revealed ., 1999) , using transfected RAG2 Ϫ/Ϫ ES cells and the RAG2 Ϫ/Ϫ blastocyst complementation assay, reported that a genomic fragment containing the RAG2 promoter region and 9 kb of 5Ј sequence is sufficient to rescue both B and T cell development, suggesting that 9 kb of sequence upstream of the RAG2 promoter has adequate information to direct RAG2 expression in both B and T lineages.
None of these studies revealed the existence of a cisregulatory element within sequences between 10 kb to 30 kb 5Ј of the RAG2 promoter. In the case of the BAC transgene reporters in particular, the region encoding Erag was fully dispensable for B cell-specific RAG expression (Yu et al., 1999) . This is surprising given the striking effect of Erag deletion reported in the present study. It is possible, however, that despite their large size, BAC transgenic reporter constructs are subject to position effects. Furthermore, these large reporters may still be missing sequences from within the locus that are necessary to see the effects of Erag. It is also possible that the BAC reporter transgenes integrate into the chromosome as tandem multicopy arrays and that this 
Flow Cytometry and Sorting
Transient Transfection Assay Single-cell suspensions from BM (two femurs), thymus, and spleen All mutations in six E2A binding sites were made using the Quickwere prepared and stained with fluorochrome (FITC, PE, or Cychange mutagenesis kit (Stratagene). The sequences of mutagenic primers used for simultaneous mutagenesis were as follows: chrome)-or biotin-conjugated (bi) monoclonal antibodies as pre-
